Ni Tang

Oct 22, 2023 | nature.com | Haijun Deng |Ni Tang

AbstractPreviously, we identified an antibody combination A8G6 that showed promising efficacy in COVID-19 animal models and favorable safety profile in preclinical models as well as in a first-in-human trial. To evaluate the real-word efficacy of A8G6 neutralizing antibody nasal spray in post-exposure prophylaxis of COVID-19, an open-label, non-randomized, two-arm, blank-controlled, investigator-initiated trial was conducted in Chongqing, China (the register number: ChiCTR2200066416).

Jun 5, 2023 | mdpi.com | Ding Zhang |Ni Tang |Dongxiao Zhang |Yanyun Qu

AltmetricshareShareannouncementHelpformat_quoteCitethumb_up... Endorsetextsms... CommentNeed Help? SupportFind support for a specific problem in the support section of our website. Get SupportFeedbackPlease let us know what you think of our products and services. Give FeedbackInformationVisit our dedicated information section to learn more about MDPI.